150 results on '"Bagot, Catherine"'
Search Results
2. Post-COVID-19 illness and associations with sex and gender
3. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
4. Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
5. Long COVID and cardiovascular disease: a prospective cohort study
6. A multisystem, cardio-renal investigation of post-COVID-19 illness
7. The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
8. The bleeding phenotype in people with nonsevere hemophilia
9. Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort
10. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study
11. Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization
12. Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort
13. A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B
14. Outcomes of total hip and knee arthroplasty in patients with haemophilia: A meta‐analysis of comparative studies and clinical practice recommendations
15. Thrombopoietin mimetic‐induced bone marrow fibrosis
16. Fibrinogenolysis and fibrinolysis in Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT)
17. Outcomes of total hip and knee arthroplasty in patients with haemophilia: A meta‐analysis of comparative studies and clinical practice recommendations.
18. Helen Cotton
19. Study of the efficacy and safety of parsaclisib in participants with primary warm autoimmune hemolytic anemia
20. Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study.
21. Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study
22. A Summary of the Evidence for VTE Prevention, with a Focus on the Controversies
23. Catastrophic venous and arterial thrombosis in a young female with cervical cancer.
24. Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
25. Chapter 41 - Hemostasis and Thrombosis
26. A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists
27. Arterial Thrombosis
28. 157 Multi-system investigation of covid-19 illness
29. Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world setting
30. Desmopressin for bleeding in non-severe hemophilia A:Suboptimal use in a real-world setting
31. Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)
32. Post-COVID-19 illness trajectory: a multisystem investigation.
33. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
34. Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia
35. Rapidly established guidelines for the diagnosis and management of vaccine‐induced thrombocytopenia and thrombosis (VITT) — a double‐edged sword?
36. Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland
37. European principles of care for women and girls with inherited bleeding disorders
38. A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate. the Flight Trial
39. List of Contributors
40. Capítulo 41 - Hemostasia y trombosis
41. Chapter 41 - Hemostasis and Thrombosis
42. History of the West of Scotland Haemophilia Centre, Glasgow, 1950–2019
43. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study
44. Thrombopoietin mimetic‐induced bone marrow fibrosis.
45. European principles of care for women and girls with inherited bleeding disorders.
46. Hereditary phytosterolaemia
47. Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study
48. Managing venous thromboembolic risk in women undergoing spontaneous or induced early pregnancy loss: a consensus statement from the British Society of Haematology Obstetric Haematology Special Interest Group.
49. Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial
50. Prevention and treatment of venous thromboembolic disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.